ArticleCancer immunology research2023

Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer.

Oluwatoyosi Adewunmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.